Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial
Open Access
- 13 July 2012
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 380 (9836), 44-49
- https://doi.org/10.1016/s0140-6736(12)60724-7
Abstract
No abstract availableKeywords
Funding Information
- Netherlands Heart Foundation (2005BO16)
- UK Medical Research Council (G108/613)
This publication has 28 references indexed in Scilit:
- Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysisCritical Care, 2011
- Intravenous Magnesium Sulphate for Aneurysmal Subarachnoid Hemorrhage (IMASH)Stroke, 2010
- Prevalence and Determinants of Cognitive Complaints after Aneurysmal Subarachnoid HemorrhageCerebrovascular Diseases, 2010
- Magnesium Sulfate Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid HemorrhageNeurosurgery Quarterly, 2009
- Modified Rankin Scale with Expanded Guidance Scheme and Interview Questionnaire: Interrater Agreement and Reproducibility of AssessmentCerebrovascular Diseases, 2006
- Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhageJournal of Clinical Pharmacy & Therapeutics, 2005
- Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatmentActa Neurochirurgica, 2003
- Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in The NetherlandsJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading ScaleJournal of Neurosurgery, 1988
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988